Literature DB >> 15115931

Indeterminate colitis: clinical spectrum of disease.

Robert Burakoff1.   

Abstract

A diagnosis of indeterminate colitis (IC) is based on endoscopic, histologic, and radiologic findings when the criteria for either Crohn's colitis or ulcerative colitis (UC) cannot be definitively established. Population-based studies have demonstrated that the average annual incidence of IC ranges 1.6 to 2.4/100,000 versus 7.3 to 13.6/100,000 for UC. At the time of initial diagnosis of inflammatory bowel disease, up to 10% to 15% of patients will be diagnosed as having IC. Over time, greater than 50% of patients with IC will be given a diagnosis of UC or Crohn's, with the majority being diagnosed with UC. Therefore, approximately 4% to 5% of all patients with inflammatory bowel disease will be left with the diagnosis of IC. Clinically, patients with IC seem to have a more severe course with a greater chance of colectomy and pouch failure. No studies have been undertaken to determine the optimum treatment regimen for IC. Recent studies have shown that patients with IC are still appropriate candidates for ileal pouch anal anastomosis. In conclusion, the current data support the premise that IC may be a separate entity, but future studies will have to focus on the genotypic and phenotypic characterization of these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15115931     DOI: 10.1097/01.mcg.0000123991.13937.7e

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.

Authors:  Billy Ray Ballard; Amosy Ephreim M'Koma
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

Review 2.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

3.  Inflammatory bowel disease unclassified.

Authors:  Ning Zhou; Wei-xing Chen; Shao-hua Chen; Cheng-fu Xu; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-04       Impact factor: 3.066

Review 4.  Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.

Authors:  Amosy Ephreim M'Koma
Journal:  Medicina (Kaunas)       Date:  2022-04-21       Impact factor: 2.948

5.  Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.

Authors:  Cosimo Prantera; Stefano Marconi
Journal:  Therap Adv Gastroenterol       Date:  2013-03       Impact factor: 4.409

6.  A comprehensive review of inflammatory bowel disease focusing on surgical management.

Authors:  Seung Hyuk Baik; Won Ho Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-06-30

7.  The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period.

Authors:  Hoda M Malaty; Seema Mehta; Bincy Abraham; Elizabeth A Garnett; George D Ferry
Journal:  Clin Exp Gastroenterol       Date:  2013-07-23

Review 8.  Secondary causes of inflammatory bowel diseases.

Authors:  Yezaz A Ghouri; Veysel Tahan; Bo Shen
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

9.  Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry.

Authors:  Jolanda M White; Siobhán O'Connor; Harland S Winter; Melvin B Heyman; Barbara S Kirschner; George D Ferry; Stanley A Cohen; Robert N Baldassano; Terry Smith; Traci Clemons; Benjamin D Gold
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-09       Impact factor: 11.382

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.